We studied the effectiveness of EMLA cream (2.5% lidocaine, 2.5% prilo
caine) in reducing distress, anxiety, and pain associated with phlebot
omy in pediatric outpatients. This was a randomized, double-blind, pla
cebo-controlled study using EMLA cream or placebo 1 hour before phlebo
tomy. Distress, anticipatory anxiety, pain, and adverse reactions rc e
re measured. Measurements of distress and ease of procedure, as well a
s changes in heart rate, showed significant improvement with EMLA crea
m as compared with placebo. Pain was decreased with use of EMLA cream.
Anticipatory anxiety levels were equal within both groups. Ratings of
cream efficacy by parent/observer scales were in favor of EMLA cream.